Jaguar Health Secures Nasdaq Compliance Extension

Jaguar Health, Inc. has addressed its Nasdaq listing concerns by regaining compliance with the publicly held shares requirement. This update follows a decision from the Nasdaq Hearings Panel, granting the company an additional extension. Previously, Nasdaq notified Jaguar about its non-compliance with the minimum 500,000 publicly held shares and the $1.00 bid price rule.

Jaguar resolved the share compliance issue after third-party investors exercised warrants, enhancing share circulation. Consequently, Jaguar now has until May 18, 2026, to meet the bid price compliance, needing a $1.00 per share closing bid for ten consecutive days. The extension reflects the company's efforts to stabilize its Nasdaq listing amid market challenges.